Edition:
India

People: Carmat SA (ALCAR.PA)

ALCAR.PA on Paris Stock Exchange

21.80EUR
16 Sep 2019
Change (% chg)

€0.30 (+1.40%)
Prev Close
€21.50
Open
€21.80
Day's High
€21.80
Day's Low
€21.55
Volume
4,095
Avg. Vol
5,615
52-wk High
€28.90
52-wk Low
€18.00

Pouletty, Philippe 

Dr. Philippe Pouletty has been the Representative of Truffle Capital on the Board of Directors of Carmat SA since May 7, 2010. He also serves as Chairman of the Company's Compensation Committee. He qualified as a Medical Doctor and Immunologist from the Universite Paris VI and then gained clinical & research experience at the Pasteur Institute, the University of Stanford and the Paris Public Hospitals group. He is cited as an inventor on 29 patents. He has been made a Knight of the French Legion of Honour and was awarded the American Liver Foundation Prize in 1999. Dr. Pouletty is a founder and General Partner of the Truffle Capital private equity firm and also has founded several biotech companies in the USA and Europe (SangStat, Conjuchem, DrugAbuse Sciences). Dr. Pouletty serves currently as Chairman of Abivax SA, Manager of Nakostech SARL.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --